Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 1612 1613 1614 1616 3774
This examiner grants 31% of resolved cases
Hong Yu has 696 resolved cases in Art Unit 1612 within Tech Center 3700. The allowance rate is 30.9%, which indicates a challenging examination process. The median pendency is 1333 days, suggesting that cases often take over three and a half years to reach allowance. This data from 696 cases provides a clear view of the examiner's rigorous approach.
The interview lift is 5.6%, which shows a modest positive impact from conducting interviews. While the 30.9% allowance rate is low, the 5.6% lift suggests that interviews can still be a tool for resolving specific issues. With a median pendency of 1333 days, the examiner appears to maintain a consistent docket. Practitioners should be prepared for a long prosecution, using the 5.6% lift where possible to address technical disagreements that arise during the process in Tech Center 3700.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18549444 | SUNSCREEN COMPOSITION | Final Rejection | DSM IP ASSETS B.V. |
| 18481588 | NAIL COMPOSITION CONTAINING DISPERSION OF ACRYLIC POLYMER PARTICLES | Final Rejection | L'OREAL |
| 17826413 | ADHESIVE MASCARA COMPOSITIONS | Final Rejection | L'ORÉAL |
| 17770089 | Film Compositions | Non-Final OA | Colgate-Palmolive Company |
| 18706281 | COSMETIC AND PERSONAL CARE COMPOSITIONS COMPRISING RECOMBINANT SILK | Non-Final OA | BOLT THREADS , INC. |
| 18612256 | Cannabinoid Self-Emulsifying Systems | Final Rejection | Fertin Pharma A/S |
| 18288508 | HIGH-HARDNESS LIQUID CRYSTAL COSMETIC COMPOSITION HAVING ELASTIC TEXTURE AND METHOD FOR PREPARING SAME | Non-Final OA | COSMAX, INC. |
| 18011903 | AN ANTIMICROBIAL COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | Non-Final OA | ISP INVESTMENTS LLC |
| 18443435 | ANTIMICROBIAL MIXTURE | Non-Final OA | SYMRISE AG |
| 15754363 | A PHARMACEUTICAL COMPOSITION FOR REDUCING LOCAL FAT AND USES THEREOF | Non-Final OA | Caliway Biopharmaceuticals Co., Ltd. |
| 18622971 | Pharmaceutical Composition and Method for Treating or Preventing Candidiasis | Final Rejection | Fempharma, LLC |
| 17560026 | ELASTOMER GEL FROM EPOXIDIZED VEGETABLE OIL AND USES THEREOF | Final Rejection | Momentive Performance Materials Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy